Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-zjyl
/
Jin Medical International Ltd
ZJYL
0.640
USD
-0.001
-0.09%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
100.21M
Market Cap
--
P/E TTM
Jin Medical International Ltd
0.640
-0.001
-0.09%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-446.45%
-1.26M
-98.18%
50.00K
--
362.91K
--
2.74M
Net income from continuing operations
54.28%
1.72M
-3.51%
1.70M
--
1.11M
--
1.77M
Operating gains losses
59.71%
177.98K
46.90%
168.15K
--
111.44K
--
114.47K
Deferred tax
-40.03%
12.62K
-65.42%
23.71K
--
21.04K
--
68.56K
Other non-cash items
113.22%
6.77K
-157.88%
-99.28K
--
-51.19K
--
171.52K
Change in working capital
-285.24%
-3.17M
-381.25%
-1.75M
--
-822.88K
--
622.08K
-Change in receivables
-960.68%
-2.88M
-882.52%
-1.02M
--
-271.79K
--
-104.29K
-Change in inventory
-143.88%
-486.42K
26.78%
566.73K
--
1.11M
--
447.02K
-Change in prepaid expenses
92.89%
-54.32K
-2854.35%
-1.31M
--
-763.86K
--
47.50K
-Change in payables and accrued expense
-183.61%
-109.21K
806.93%
206.42K
--
-38.51K
--
-29.20K
-Change in other current assets
--
--
--
--
--
--
--
0.00
-Change in other current liabilities
-49.73%
96.23K
6.54%
-159.98K
--
191.43K
--
-171.17K
Cash from non-recurring investing activities
Cash from operating activities
-446.45%
-1.26M
-98.18%
50.00K
--
362.91K
--
2.74M
Investing cash flow
Net cash from continuing investing activities
-35.55%
59.86K
9649.17%
1.06M
--
92.89K
--
10.91K
Capital expenditures
-40.47%
61.27K
9563.81%
1.06M
--
102.92K
--
11.01K
Net cash flow from disposal of fixed assets
-35.55%
59.86K
9649.17%
1.06M
--
92.89K
--
10.91K
Net cash flow from investment products
80.00%
-1.06M
-218.15%
-7.33M
--
-5.32M
--
-2.30M
Net cash flow from other investing activities
-189.07%
-4.24M
189.07%
4.24M
--
4.76M
--
-4.76M
Cash from non-current investing activities
Net cash flow from investing activities
-717.28%
-5.36M
41.34%
-4.15M
--
-656.42K
--
-7.07M
Financing cash flow
Cash flow from continuous financing activities
575.09%
5.65M
-25.87%
6.00M
--
-1.19M
--
8.10M
Net cash flow from debt Issuance/repayment
-53.47%
1.31M
287.58%
5.55M
--
2.82M
--
1.43M
Net cash flow from common stock issuance/repurchase
--
0.00
-96.10%
312.00K
--
0.00
--
8.00M
Net cash flow from preferred stock issuance/repurchase
--
--
100.00%
0.00
--
0.00
--
-1.21M
Proceeds from stock option exercised by employees
--
--
--
--
--
336.64K
--
--
Net cash flow from other financing activities
199.78%
4.34M
214.87%
138.22K
--
-4.35M
--
-120.33K
Net cash from non-recurrent financing activities
Net cash from financing activities
575.09%
5.65M
-25.87%
6.00M
--
-1.19M
--
8.10M
Net cash flow
Beginning cash balance
2.20%
8.87M
44.59%
6.93M
--
8.68M
--
4.79M
Current period cash flow changes
57.90%
-738.72K
-50.01%
1.95M
--
-1.75M
--
3.89M
Effect of exchange rate changes
185.80%
233.29K
-66.94%
40.34K
--
-271.90K
--
122.00K
Ending cash balance
17.41%
8.14M
2.20%
8.87M
--
6.93M
--
8.68M
Free cash flow
-607.17%
-1.32M
-137.12%
-1.01M
--
259.99K
--
2.73M
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up